EU drug regulator begins real-time review of Sinovac’s COVID-19 vaccine
FILE PHOTO: A healthcare worker prepares a syringe with a dose of Sinovac’s COVID-19 vaccine at the Bang Khun Thian Geriatric Hospital in Bangkok, Thailand April 21, 2021. REUTERS/Athit Perawongmetha
Europe’s medicines regulator said on Tuesday it has started a real-time review of Sinovac’s COVID-19 vaccine, based on preliminary results from animal and human trials that suggested the vaccine produces an immune response against the coronavirus.
Data on the vaccine, COVID-19 Vaccine (Vero Cell) Inactivated, will be assessed as they are made available to help speed up potential approvals, the European Medicines Agency said.
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
